SCHEDULE 13D/A

NATURES SUNSHINE PRODUCTS INC

Common Stock, no par value · CUSIP: 639027101

Event date: 2025-06-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Reported CIK 0001615258

  Shares: 2,918,774 · Class: 15.9%

• Fosun Pharma USA Inc.

  Shares: 2,854,607 · Class: 15.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.